Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
81.84B | 55.17B | 57.20B | 72.64B | 92.79B | 77.72B |
Gross Profit | |||||
72.05B | 55.17B | 48.48B | 72.64B | 92.79B | 77.72B |
EBIT | |||||
7.89B | 53.80B | 6.31B | 4.46B | 4.16B | 3.08B |
EBITDA | |||||
5.72B | 0.00 | -1.19B | 4.82B | 5.59B | 4.76B |
Net Income Common Stockholders | |||||
4.28B | 3.72B | 3.75B | 2.91B | 2.85B | 1.74B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.07B | 8.31B | 7.07B | 287.67B | 357.05B | 344.90B |
Total Assets | |||||
501.43B | 538.65B | 507.23B | 519.05B | 586.23B | 544.71B |
Total Debt | |||||
21.82B | 37.54B | 15.20B | 16.48B | 16.57B | 13.42B |
Net Debt | |||||
15.75B | 29.23B | 8.13B | 9.24B | 8.10B | 5.52B |
Total Liabilities | |||||
473.17B | 505.55B | 475.94B | 500.91B | 554.35B | 512.92B |
Stockholders Equity | |||||
27.06B | 30.39B | 28.97B | 16.20B | 29.31B | 30.03B |
Cash Flow | Free Cash Flow | ||||
9.89B | 0.00 | 1.55B | 9.90B | 29.39B | 19.01B |
Operating Cash Flow | |||||
10.20B | 0.00 | 1.73B | 10.54B | 17.48B | 19.34B |
Investing Cash Flow | |||||
-8.63B | 0.00 | 2.27B | -9.54B | -16.30B | -15.98B |
Financing Cash Flow | |||||
-3.28B | 0.00 | -3.80B | -2.22B | -677.00M | -2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | €12.61B | 11.73 | 12.42% | 4.83% | 6.46% | -2.42% | |
72 Outperform | €16.29B | 12.46 | 11.91% | 5.62% | 17.52% | 24.02% | |
64 Neutral | $12.85B | 9.81 | 7.59% | 16985.65% | 12.30% | -7.71% | |
64 Neutral | €50.15B | 13.42 | 12.66% | 4.40% | 12.38% | -0.28% |